BIOTECH ACQUISITION COMPANY - UNIT 11/30/2027 (BIOTU)

CUSIP: G1125A124

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / UNIT 11/30/2027
Total 13F shares
12,074,365
Share change
+12,024,365
Total reported value
$119,435,000
Price per share
$9.89
Number of holders
59
Value change
+$118,940,000
Number of buys
58

Quarterly Holders Quick Answers

What is CUSIP G1125A124?
CUSIP G1125A124 identifies BIOTU - BIOTECH ACQUISITION COMPANY - UNIT 11/30/2027 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BIOTECH ACQUISITION COMPANY - UNIT 11/30/2027 (BIOTU) as of Q1 2021

As of 31 Mar 2021, BIOTECH ACQUISITION COMPANY - UNIT 11/30/2027 (BIOTU) was held by 59 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,074,365 shares. The largest 10 holders included ARISTEIA CAPITAL LLC, HGC Investment Management Inc., GLAZER CAPITAL, LLC, BlueCrest Capital Management Ltd, Linden Advisors LP, Sage Rock Capital Management LP, Periscope Capital Inc., DG Capital Management, LLC, Magnetar Financial LLC, and Radcliffe Capital Management, L.P.. This page lists 59 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.